Ocean(a) – Prevent First Major Cardiovascular Events

  • Study Sponsor and Protocol Number: 
    Amgen, Inc / 20230222
  • Specialty:
    Internal Medicine / Cardiology
  • Type:
    Investigational Drug
  • Inclusion:
    Lp(a) >200 nmol/L at screening
    Multiple risk factors for atherosclerotic disease (as defined by protocol)
  • Exclusion:
    Prior myocardial infarction, stroke, transient ischemic attach or limb ischemia
    Prior arterial revascularization associated with atherosclerosis